Ptc Therapeutics (PTCT) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to $79.9 million.
- Ptc Therapeutics' Shares Outstanding rose 387.21% to $79.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.9 million, marking a year-over-year increase of 387.21%. This contributed to the annual value of $77.7 million for FY2024, which is 263.55% up from last year.
- Latest data reveals that Ptc Therapeutics reported Shares Outstanding of $79.9 million as of Q3 2025, which was up 387.21% from $79.4 million recorded in Q2 2025.
- Over the past 5 years, Ptc Therapeutics' Shares Outstanding peaked at $79.9 million during Q3 2025, and registered a low of $70.4 million during Q1 2021.
- For the 5-year period, Ptc Therapeutics' Shares Outstanding averaged around $74.6 million, with its median value being $75.3 million (2023).
- Its Shares Outstanding has fluctuated over the past 5 years, first skyrocketed by 1218.54% in 2021, then skyrocketed by 132.25% in 2022.
- Quarter analysis of 5 years shows Ptc Therapeutics' Shares Outstanding stood at $70.8 million in 2021, then grew by 3.21% to $73.1 million in 2022, then grew by 3.56% to $75.7 million in 2023, then grew by 2.64% to $77.7 million in 2024, then increased by 2.87% to $79.9 million in 2025.
- Its Shares Outstanding stands at $79.9 million for Q3 2025, versus $79.4 million for Q2 2025 and $79.2 million for Q1 2025.